Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

EPDS can cause recurring scalp sores and hair loss if not treated.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

A man had a rare skin cancer that looked like a bald spot.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.